Betty Dong, PharmD

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address2540 23rd Street, #5542
San Francisco CA 94110
Phone628-206-5794
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San Francisco Residency School of Pharmacy
    University of California, San FranciscoPharm.D.1972 School of Pharmacy
    Collapse awards and honors
    Pharmacists Planning Services, INC (PPSI)2016Distinguished Person of the Year
    Hepatitis Task Force San Francisco, CA2017Honorable Mention Hepatitis C Champion
    UCSF School of Pharmacy2018  - 2019Dean's Recognition for Excellence in Teaching
    American Pharmacist Association2019Daniel B. Smith Practice Excellence Award
    American College of Clinical Pharmacy2019Special Recognition: ACSAP Editors

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California. J Acquir Immune Defic Syndr. 2024 Oct 01; 97(2):142-149. Beltran RM, Hunter LA, Packel LJ, De Martini L, Holloway IW, Dong BJ, Lam J, McCoy SI, Ochoa AM. PMID: 39250648; PMCID: PMC11386963.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. HIV pre-exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States. J Am Coll Clin Pharm. 2024 May; 7(5):458-470. Saberi P, Su H, Mendiola J, Gruta C, Lutes ER, Dong B, Bositis C, Chu C. PMID: 40125524; PMCID: PMC11928167.
      View in: PubMed   Mentions:
    3. Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California. Open Forum Infect Dis. 2023 Nov; 10(11):ofad549. Hunter LA, Packel LJ, Chitle P, Beltran RM, Rafie S, De Martini L, Dong B, Harris O, Holloway IW, Miyashita Ochoa A, McCoy SI. PMID: 38023549; PMCID: PMC10651201.
      View in: PubMed   Mentions: 3  
    4. Patterns of Prescribing Antiretroviral Therapy Upon Discharge to Psychiatry Inpatients With HIV/AIDS at a Large Urban Hospital. Ann Pharmacother. 2021 04; 55(4):452-458. Momenzadeh A, Shumway M, Dong BJ, Dilley J, Nye J, Mangurian C. PMID: 32885983.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss! J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):e18-e24. Lopez MI, Grant RM, Dong BJ. PMID: 32165026.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    6. Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States. Open Forum Infect Dis. 2019 Dec; 6(12):ofz497. Dong BJ, Lopez MI, Grant RM. PMID: 31824977; PMCID: PMC6892568.
      View in: PubMed   Mentions: 2  
    7. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):138-144. Lopez MI, Cocohoba J, Cohen SE, Trainor N, Levy MM, Dong BJ. PMID: 31405804.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    8. Outcome of challenging HIV case consultations provided via teleconference by the Clinician Consultation Center to the Federal Bureau of Prisons. J Am Pharm Assoc (2003). 2017 Jul - Aug; 57(4):516-519. Dong BJ, Williams MR, Bingham JT, Tokumoto J, Allen JD. PMID: 28610939.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project. J Am Pharm Assoc (2003). 2017 Jul - Aug; 57(4):510-515.e2. Dong BJ, Lopez M, Cocohoba J. PMID: 28602784.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    10. Initial Management of Patients with HIV Infection. Am Fam Physician. 2016 Nov 01; 94(9):708-716. Goldschmidt RH, Chu C, Dong BJ. PMID: 27929247.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection. Expert Opin Drug Saf. 2016 Sep; 15(9):1287-94. Trang TP, Dong BJ, Kojima N, Klausner JD. PMID: 27391203.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    12. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2014 Dec; 34(12):1341-54. Mohammad RA, Bulloch MN, Chan J, Deming P, Love B, Smith L, Dong BJ. PMID: 25359244.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    13. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. Cocohoba J, Dong BJ, Johnson MO, Saberi P. PMID: 24467531; PMCID: PMC4112174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Center for the Advancement of Pharmacy Education 2013 educational outcomes. Am J Pharm Educ. 2013 Oct 14; 77(8):162. Medina MS, Plaza CM, Stowe CD, Robinson ET, DeLander G, Beck DE, Melchert RB, Supernaw RB, Roche VF, Gleason BL, Strong MN, Bain A, Meyer GE, Dong BJ, Rochon J, Johnston P. PMID: 24159203; PMCID: PMC3806946.
      View in: PubMed   Mentions: 388     Fields:    Translation:Humans
    15. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41. Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT, AIDS Clinical Trials Group Study 5208 Team. PMID: 22301417; PMCID: PMC3506024.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    16. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. PMID: 22536064; PMCID: PMC3333818.
      View in: PubMed   Mentions: 36  
    17. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Ann Pharmacother. 2011 Dec; 45(12):1499-505. Sherman EM, Cocohoba JM, Neff SE, Dong BJ. PMID: 22085777.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    18. Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008 Oct; 30(10):1747-65. Cocohoba J, Dong BJ. PMID: 19014832.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    19. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. PMID: 18413688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Tipranavir: a protease inhibitor for HIV salvage therapy. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1311-21. Dong BJ, Cocohoba JM. PMID: 16788094.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Advances in human immunodeficiency virus therapeutics. Ann Pharmacother. 2006 Apr; 40(4):704-9. Clay PG, Dong BJ, Sorensen SJ, Tseng A, Romanelli F, Antoniou T. PMID: 16551767.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther. 2005 Nov; 27(11):1725-51. Dong BJ. PMID: 16368445.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    23. Outcomes of dual-protease inhibitor salvage therapy in human immunodeficiency virus-infected patients referred to a telephone consultation service. Pharmacotherapy. 2003 Sep; 23(9):1100-4. Lim ML, Dong BJ, Hart SL. PMID: 14524642.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Treatment of AIDS and HIV-related conditions--2002: antiretroviral therapy. J Am Board Fam Pract. 2002 Jul-Aug; 15(4):319-31. Goldschrnidt RH, Dong BJ. PMID: 12150468.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Betty's Networks
    Concepts (119)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.